TYLER BALLARD: Open Payments
NPI 1679058630 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 50 payments from 10 companies in 2025. Trend: 2023 $497 · 2024 $497 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $225 |
| Lilly USA, LLC | 8 | $141 |
| Novo Nordisk Inc | 7 | $135 |
| PFIZER INC. | 6 | $132 |
| Exact Sciences Corporation | 3 | $58 |
| Tonix Medicines, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: MOUNJARO, VRAYLAR, ELIQUIS, QULIPTA, Rybelsus, Ozempic, Cologuard Collection Kit, UBRELVY.
Industry payments across MI — which companies pay providers there.
